NCT07669337

Brief Summary

Transurethral resection of the prostate (TURP) is a widely performed surgical procedure for the management of benign prostatic hyperplasia. Because of the constant and frequently undetectable fluid exchange through the open prostatic venous sinuses, it is difficult to determine the precise amount of irrigating fluid absorbed after TURP surgery. Unpredictable intravascular volume changes may result from this. While over-resuscitation raises the risk of fluid overload, pulmonary edema, and cardiac events, under-resuscitation in older individuals can lead to hypotension and decreased organ perfusion. Fluid management in TURP has always depended on traditional techniques that employ clinical evaluations like blood pressure and heart rate monitoring or fixed-volume infusion procedures. By using advanced technologies, goal-directed fluid therapy (GDFT) methods continually monitor and evaluate a patient's physiological status in real time, modifying fluid dosage as necessary. A dynamic method for determining volume status, the plethysmography variability index (PVI) has been studied in numerous clinical settings and has proven reliable in predicting fluid responsiveness and acting as a fluid resuscitation guide

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for not_applicable

Timeline
6mo left

Started Mar 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Mar 2016Feb 2027

Study Start

First participant enrolled

March 15, 2016

Completed
10.3 years until next milestone

First Submitted

Initial submission to the registry

June 20, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 25, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2027

Last Updated

July 7, 2026

Status Verified

July 1, 2026

Enrollment Period

10.8 years

First QC Date

June 20, 2026

Last Update Submit

July 4, 2026

Conditions

Keywords

begnin prostatic hyperplasiatransurethral resection of the prostate

Outcome Measures

Primary Outcomes (1)

  • The total amount of intraoperative crystalloid administered by each group.

    the amount of crystalloids bottles given to the patient during the intra operative period

    24 hours

Study Arms (2)

Conventional Fluid Management.

ACTIVE COMPARATOR

Participants will receive conventional intraoperative fluid management according to the study protocol, based on mean arterial pressure (MAP) monitoring and fluid administration as clinically indicated.

Other: Conventional Fluid Management

PVI-Guided Goal-Directed Fluid Manage

EXPERIMENTAL

Participants will receive intraoperative fluid management guided by Plethysmography Variability Index (PVI) measurements according to the study protocol, with fluid administration adjusted based on PVI values and hemodynamic parameters.

Other: Plethysmography Variability Index (PVI)-Guided Goal-Directed Fluid Management

Interventions

Participants will receive conventional intraoperative fluid management according to the study protocol, based on mean arterial pressure (MAP) monitoring and fluid administration as clinically indicated.

Conventional Fluid Management.

Participants will receive intraoperative fluid management guided by Plethysmography Variability Index (PVI) measurements according to the study protocol, with fluid administration adjusted based on PVI values and hemodynamic parameters.

PVI-Guided Goal-Directed Fluid Manage

Eligibility Criteria

Age40 Years - 80 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male patients aged from 50 to 80 years Scheduled for elective TURP.
  • ASA Ⅰ, Ⅱ.

You may not qualify if:

  • Cardiac arrhythmias (e.g., atrial fibrillation)
  • Left ventricular ejection fraction \<40%
  • Chronic kidney disease (stage ≥ 3)
  • Hepatic dysfunction
  • Peripheral vascular disease
  • Prolonged procedures more than 2 hours or complicated procedures with severe bleeding affecting management (Severe bleeding will be defined as any of the following: a drop in hemoglobin of ≥ 2 g/dl, hemodynamic instability due to blood loss that requires blood transfusion).
  • Patients refuse to share in this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo University Hospitals Anesthesia Department

Cairo, Egypt

Location

Related Publications (3)

  • Kadir Arslan ASŞ. Transurethral Resection of the Prostate (TURP) Syndrome: A Review of Perioperative Management. Comprehensive Medicine 2024;16(2):123-7.

    BACKGROUND
  • Pandya DS. TURP Syndrome. Practical Guidelines on Fluid Therapy. Third ed2024. p. 537-43.

    BACKGROUND
  • Tapscott AH, Hakim LS. Office-based management of impotence and Peyronie's disease. Urol Clin North Am. 2013 Nov;40(4):521-43. doi: 10.1016/j.ucl.2013.07.003. Epub 2013 Sep 3.

    PMID: 24182973BACKGROUND

MeSH Terms

Conditions

Prostatic Hyperplasia

Condition Hierarchy (Ancestors)

Prostatic DiseasesGenital Diseases, MaleGenital DiseasesUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • mariam saeed toukhy, master degree of anesthesia

    anesthesia department at cairo univesrsity hospitals

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
This randomized controlled trial (RCT) aims to compare the clinical outcomes of conventional fluid management with PVI-based GDFT in patients undergoing TURP. We hypothesize that PVI-guided fluid management will result in better intraoperative hemodynamic stability, a reduction in postoperative complications, and an overall improvement in patient recovery.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned in a 1:1 ratio to one of two parallel groups: conventional fluid management or plethysmography variability index (PVI)-guided goal-directed fluid management during transurethral resection of the prostate (TURP). Outcomes will be compared between the two groups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 20, 2026

First Posted

June 25, 2026

Study Start

March 15, 2016

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

February 1, 2027

Last Updated

July 7, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

No plan for sharing individual participant data has been developed for this study

Locations